Ventlab Manual Resuscitator Recall Issued Due to Risk of Death, Injury

More than 14,000 Ventlab manual resuscitators are being recalled, due to the risk of potential leaks, which could put patients’ lives in danger. 

The manual resuscitator recall was announced by the FDA last week, impacting devices manufactured by Ventlab Corporation and sold under a number of different brand names.

Included are the Airflow, Statcheck, SafeSpot, Premium and RescueMed resuscitators sold under the Ventlab label; the Provider Enterprises Adult Resuscitator; as well as the SafeSpot Infant Resuscitators sold under the Provider and BreathTech labels.

Do You Know About...

Childhood Diabetes Lawsuits Against Junk Food Industry

Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods.

Learn More

The action has been categorized as a Class I medical device recall, indicating that the FDA believes the continued use of the manual resuscitators pose a reasonable probability of causing severe injury or death. However, there are reportedly no injuries or deaths related linked to the devices.

The recalled resuscitators are used to deliver temporary breathing support to adults and children when they are unable to breathe on their own. They are used by emergency medical technicians and health care professionals.

The Ventlab Manual resuscitator units have a valve leak that may prevents the oxygen from getting to the patient. The leak may not be immediately apparent, because the bag still deflates as normal when compressed. The problem was discovered when a defective resuscitator was used by a customer.

The recall affects 14,602 disposable, manual resuscitators, with a complete list of affected lot numbers available in the recall notice. The products can be identified by the part number, description and the lot numbers, which are located on small white labels on the packaging bag. They were manufactured and distributed between March and July 2012.

In June, Ventlab Corporation sent a letter to customers, requesting that they check their inventories for certain resuscitators and return a response form to let the company know if it had them in stock. The company is now in the process of arranging to have the affected units replaced. Customers with questions can call (800) 593-5654 or sent an email to csr@ventlab.com.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women
Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (Posted 2 days ago)

Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera.

Court Asked To Establish Valsartan Settlement Fund and Appoint Administrator
Court Asked To Establish Valsartan Settlement Fund and Appoint Administrator (Posted 3 days ago)

The judge presiding over the federal Valsartan lawsuits has been asked to approve the creation of a qualified settlement fund, as well as appoint an administrator and custodian for funds that will be paid to former users of the recalled hypertension drugs who have developed cancer.